Overview
Stinging nettle (Urtica dioica) is a flowering plant with a long history of traditional medicinal use, now increasingly studied for its effects on various health conditions. The plant contains a diverse array of bioactive compounds including lectins, polysaccharides, sterols, and flavonoids. Two primary forms are used medicinally: root extracts, which are most commonly studied for prostate health, and leaf extracts, which are typically used for allergy relief and anti-inflammatory support.
The supplement is available in oral and topical formulations, with dosing ranging from 300–600 mg twice daily orally or 1–2% cream/gel formulations applied 2–3 times daily topically. At standard doses, stinging nettle is generally well-tolerated with a favorable safety profile in healthy adults, though caution is warranted in specific populations including pregnant individuals and those with diabetes, low blood pressure, or those taking anticoagulant or diuretic medications.
This comprehensive guide examines the scientific evidence supporting various health claims, dosing protocols, safety considerations, and cost-benefit analysis to help you make informed decisions about whether stinging nettle supplementation may be appropriate for your health goals.
How Stinging Nettle Works: Mechanism of Action
Stinging nettle exerts its effects through multiple mechanisms, varying somewhat between root and leaf extracts.
Root Extract Mechanisms (Prostate Health)
The root extract appears to influence hormonal pathways relevant to benign prostatic hyperplasia (BPH). Nettle root inhibits sex hormone-binding globulin (SHBG) binding to its receptor, which affects the availability of sex hormones in tissue. Additionally, it modulates 5-alpha-reductase activity—an enzyme that converts testosterone to dihydrotestosterone (DHT)—contributing to reduced prostate tissue proliferation. The root also contains compounds that inhibit the enzyme aromatase and interact with androgen receptors, mechanisms that collectively influence hormonal balance and prostate physiology.
Leaf Extract Mechanisms (Anti-Inflammatory and Antihistamine Effects)
Leaf extracts suppress pro-inflammatory cytokines including TNF-alpha, IL-1, and NF-kB signaling pathways, which explain the anti-inflammatory and antihistamine properties reported in traditional use. These mechanisms are supported by both in vitro and animal model evidence, though human clinical confirmation remains limited for many conditions.
Evidence by Health Goal
Joint Health — Tier 3 (Probable Efficacy)
Stinging nettle shows probable efficacy for joint health based on human randomized controlled trials (RCTs) demonstrating significant reductions in osteoarthritis pain and functional disability. However, most available evidence comes from multi-ingredient formulations, making attribution to nettle alone difficult to establish.
A combination formula of rosehip, nettle, and devil's claw (MA212) reduced WOMAC pain scores by 29.87 points versus 10.23 points for placebo over 12 weeks (p<0.001, n=92, RCT). Another combination formula containing fish oil, nettle, and vitamin E (Phytalgic) reduced analgesic tablet use from 16.5 to 6.5 tablets per week compared to placebo, and reduced NSAID use from 1.0 to 0.4 defined daily doses per day over 3 months (p<0.001 and p=0.02, n=81, RCT). While these results are encouraging, sample sizes remain relatively small (n=27–92 across studies), limiting the strength of conclusions.
Heart Health — Tier 3 (Probable Efficacy)
Stinging nettle shows probable efficacy for heart health markers, primarily in type 2 diabetes patients. A meta-analysis of 13 RCTs found that nettle consumption reduced systolic blood pressure by 5.03 mmHg (95% confidence interval: −8.15 to −1.91) and decreased triglycerides by 26.94 mg/dL (95% CI: −52.07 to −1.82) compared to control groups. These improvements in blood pressure and triglyceride levels are modestly beneficial but should not replace standard cardiovascular medications or lifestyle interventions.
Liver Health — Tier 3 (Probable Efficacy)
Stinging nettle shows probable benefit for liver health in diabetic patients, primarily through improved glucose metabolism rather than direct hepatoprotective effects. A double-blind RCT found that nettle leaf extract (500 mg three times daily for 3 months) reduced fasting glucose by 25% and HbA1c by 15% in advanced type 2 diabetic patients (n=46), without measurable effects on liver enzyme markers (SGOT/SGPT). A larger herbal combination study involving nettle reduced fasting glucose by 20% and cholesterol significantly compared to placebo in type 2 diabetic patients (n=150, 3-month duration).
Hormonal Balance & Prostate Health — Tier 2 (Emerging Efficacy)
Stinging nettle shows the strongest human evidence for benign prostatic hyperplasia (BPH) symptom improvement. An RCT of 620 men found that nettle root reduced International Prostate Symptom Score (IPSS) from 19.8 to 11.8 versus a decrease from 19.2 to 17.7 in the placebo group over 6 months (p=0.002). Peak urinary flow rates improved by 8.2 mL/s with nettle versus 3.4 mL/s with placebo (p<0.05), indicating meaningful functional improvements in urinary symptoms.
Fat Loss — Tier 2 (Emerging Efficacy)
Stinging nettle shows consistent beneficial effects on fat loss and metabolic parameters in rodent models, with emerging evidence from a small human observational study on polycystic ovary syndrome (PCOS). However, efficacy in humans remains unproven due to the lack of dedicated human RCTs specifically testing fat loss as a primary outcome.
In mice fed a high-fat diet, nettle vegetable at 9% of diet attenuated weight gain and fat accumulation in mesenteric, perirenal, and retroperitoneal fat pads compared to control (p<0.005, n=9). Lower doses of nettle (2–4%) protected against insulin resistance and prevented high-fat diet-induced decreases in intestinal T cells and IgA+ B cells in mice. These findings suggest potential metabolic benefits, but translation to human weight loss remains speculative.
Anti-Inflammation — Tier 2 (Emerging Efficacy)
Stinging nettle shows anti-inflammatory effects in animal models and in vitro studies, with one small human RCT demonstrating modest benefits for allergic rhinitis. In the allergic rhinitis study (n=40 completers), nettle treatment produced a significant reduction in nasal eosinophil counts post-treatment (P<0.01), though symptom improvement on the SNOT-22 symptom score was similar between nettle and placebo groups, and IgE and IL-4/IL-5 levels showed no significant changes.
In a rat model of Crohn's disease, nettle extract reduced degenerative and necrotic tissue changes and mononuclear cell infiltration, with reduced TNF-α immunoreactivity compared to disease control, suggesting potential anti-inflammatory activity in gastrointestinal inflammation.
Injury Recovery — Tier 2 (Emerging Efficacy)
Stinging nettle shows promise for wound healing in animal models with consistent positive effects on closure rates and tissue regeneration, but human evidence is minimal. A hydroethanolic extract of nettle increased wound closure to 92.39% by day 11 in rats versus 60.91% in control animals (n=24 rats, p<0.01). A saponin extract from nettle achieved 100% wound closure in 15 days in rats, superior to the reference product Madécassol at 93.73% over the same duration. Efficacy in humans for injury recovery remains plausible but unproven.
Gut Health — Tier 2 (Emerging Efficacy)
Stinging nettle shows plausible mechanisms for gut health support through antioxidant and anti-inflammatory effects, but evidence of direct efficacy in humans is limited. In a rat Crohn's disease model, nettle extract improved degenerative and necrotic gastric changes and reduced mononuclear cell infiltration versus TNBS control, with normalized TNF-α and caspase-3 expression. A human RCT (n=150) using nettle in a herbal combination for diabetes showed a 25% decrease in fasting glucose and 15% decrease in HbA1c versus baseline after 3 months, comparable to metformin monotherapy, suggesting systemic metabolic benefits that may support gastrointestinal health indirectly.
Cognition — Tier 2 (Emerging Efficacy)
Stinging nettle shows neuroprotective promise in animal models through antioxidant and anti-inflammatory mechanisms, but human evidence for cognition is extremely limited. A methanol extract of nettle inhibited acetylcholinesterase with an IC50 = 0.098 ± 0.011 mg/mL in vitro, suggesting potential for supporting cognitive function via inhibition of acetylcholine breakdown. In rats with streptozotocin-induced neurodegeneration, nettle (50 mg/kg/day for 4 weeks) slightly attenuated memory deficits and increased autophagy markers Beclin, ATG5, and LC3β expression in the hippocampus. No human clinical trials have demonstrated cognitive benefits to date.
Longevity — Tier 2 (Emerging Efficacy)
Stinging nettle shows promise for longevity-related outcomes through antioxidant and anti-inflammatory mechanisms, primarily in animal models and mechanistic studies. A meta-analysis of 13 human RCTs found that nettle reduced fasting blood glucose by 17.17 mg/dL (95% CI: −26.60 to −7.73) and HbA1c by 0.93 (95% CI: −1.66 to −0.17) in type 2 diabetes patients, with systolic blood pressure reduced by 5.03 mmHg. These metabolic improvements may support healthspan, though direct human evidence for lifespan extension is absent.
Immune Support — Tier 2 (Emerging Efficacy)
Stinging nettle demonstrates immunomodulatory activity in animal and in vitro studies, though meaningful human evidence of immune efficacy is largely absent. Two animal studies in broiler chickens found that 5% nettle powder significantly increased lysozyme and myeloperoxidase activity with enhanced relative percentage survival against Aeromonas hydrophila. Nettle seed supplementation (5–15 g/kg) in broiler chickens significantly improved cellular immunity markers (DHT) and antibody titers against Newcastle disease, with increased bursa of Fabricius relative weight. No equivalent human RCTs have been conducted.
Energy — Tier 2 (Emerging Efficacy)
One small human RCT found that higher-dose stinging nettle reduced Gulf War Illness symptoms (p=0.048, n=29), but this is an isolated positive result in a specialized disease population. No human studies demonstrate efficacy for general energy enhancement. In diabetic mice, nettle administration reduced oxidative stress markers and ameliorated mitochondrial damage in brain tissue (p<0.05), suggesting potential benefits for energy metabolism in disease states.
Mood & Stress — Tier 2 (Emerging Efficacy)
Stinging nettle shows plausible but unproven efficacy for mood and stress in humans. In a human RCT (n=29 Gulf War Illness veterans, crossover design), higher-dose stinging nettle significantly reduced symptom severity compared to placebo (p=0.048), while lower-dose showed no effect (p=0.604). In a double-blind RCT of tinnitus patients (n=103), mood disturbance improved only in the herbal intervention group containing nettle (p<0.05) versus the control group. Most evidence comes from animal studies and mechanistic reviews rather than dedicated human trials.
Skin & Hair — Tier 2 (Emerging Efficacy)
Stinging nettle shows plausible mechanisms for hair loss through 5-alpha-reductase inhibition and is traditionally used for hair and skin conditions, but human efficacy for hair growth remains unproven. In human HaCaT skin cells, nettle extract treatment produced a 41.3% reduction in 5α-RII gene expression (fold change 0.5873±0.0586, p=0.0021), suggesting potential for reducing DHT-driven hair loss. A computational study identified nettle phytochemicals as potential 5-alpha-reductase inhibitors comparable to finasteride and dutasteride, though empirical validation in human hair follicles has not been provided.
Sexual Health — Tier 2 (Emerging Efficacy)
Stinging nettle shows emerging promise for sexual health based on limited human data and animal studies. In an observational study (n=100), nettle combined with saw palmetto and bromeline (Prostamev Plus) achieved better improvements in IPSS score, urinary flow, and sexual life compared to saw palmetto extract alone after 2 months. In mice (n=56), nettle extract (10–50 mg/kg) significantly increased sperm motility, count, normal morphology, seminiferous tubule diameter, and testosterone levels in nicotine-exposed mice compared to nicotine-only controls (p=0.00).
Athletic Performance — Tier 2 (Emerging Efficacy)
Stinging nettle combined with exercise training shows consistent improvements in metabolic and cognitive parameters in diabetic animal models, but no human studies exist to demonstrate efficacy for athletic performance. Combined nettle extract and endurance training significantly lowered blood glucose and liver malondialdehyde (MDA) levels in diabetic rats compared to diabetes alone (p<0.05), with a synergistic three-way interaction observed (p<0.001). Nettle extract with exercise increased cardiac ATP content, citrate synthase activity, and ejection fraction in diabetic rats, indicating improved mitochondrial function and cardiac performance.
Muscle Growth — Tier 1 (No Evidence)
Stinging nettle has not been studied for muscle growth in humans. Among 50 PubMed articles in the available dataset, focus areas include diabetes, cancer, viral infections, and other health conditions—not skeletal muscle hypertrophy or athletic performance. Zero human RCTs examine stinging nettle for muscle growth, strength, or lean mass outcomes. All animal studies (n=15) and in vitro studies (n=9) focus on metabolic, anti-inflammatory, or antimicrobial endpoints rather than skeletal muscle physiology.